Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IBRX
IBRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IBRX News
ImmunityBio's Bladder Cancer Drug Trial Confirms Statistical Power
2d ago
Yahoo Finance
ImmunityBio Faces Class Action Lawsuit
4h ago
Globenewswire
ImmunityBio Faces Class Action Over Misleading Claims
9h ago
Globenewswire
Analysis of XBI ETF's 52-Week Price Fluctuations
11h ago
NASDAQ.COM
ImmunityBio Under Investigation for Possible Securities Law Violations
13h ago
Newsfilter
ImmunityBio Faces Class Action Lawsuit Over Anktiva Claims
15h ago
Globenewswire
IBRX Stock Poised for Breakout Quarter: Anktiva Launches Phase 2 Long COVID Trial Amid European Expansion Plans
19h ago
stocktwits
ImmunityBio Faces Class Action Lawsuit
1d ago
Globenewswire
Class Action Filed Against ImmunityBio Securities
1d ago
Globenewswire
Faruqi & Faruqi Investigates Potential Claims Against ImmunityBio
1d ago
PRnewswire
ImmunityBio Faces Class Action Lawsuit Reminder
1d ago
Newsfilter
ImmunityBio Faces Securities Class Action Lawsuit Over Misleading Claims
3d ago
Globenewswire
Class Action Lawsuit Filed Against ImmunityBio, Inc.
3d ago
PRnewswire
ImmunityBio Faces Class Action Lawsuit
3d ago
PRnewswire
ImmunityBio Investors Class Action Notice Issued
3d ago
Globenewswire
ImmunityBio Accused of Misleading Investors
3d ago
Globenewswire
Show More News
